Kevin Matthew GARDINIER

Person

Arlington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 12,122,761
- Issue date Oct 22, 2024
- Novartis AG
- Amy Calhoun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,820,778
- Issue date Nov 21, 2023
- Novartis AG
- Amy Calhoun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,548,865
- Issue date Jan 10, 2023
- Novartis AG
- Amy Calhoun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,485,742
- Issue date Nov 1, 2022
- Novartis AG
- Amy Calhoun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED TETRAHYDROPYRROLO-PYRIDINONE COMPOUNDS AND THEIR USE IN...
- Publication number 20240336619
- Publication date Oct 10, 2024
- Kevin Matthew Gardinier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
"Cyclopenta[c]pyrrol Negative Allosteric Modulators of NR2B"
- Publication number 20240208953
- Publication date Jun 27, 2024
- Novartis AG
- Kevin Matthew GARDINIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20240140959
- Publication date May 2, 2024
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20230212139
- Publication date Jul 6, 2023
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20220411435
- Publication date Dec 29, 2022
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20210130365
- Publication date May 6, 2021
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20210107889
- Publication date Apr 15, 2021
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kevin Matthew GARDINIER

Person

Patents Grantslast 30 patents

2-azaspiro[3.4]octane derivatives as M4 agonists

2-azaspiro[3.4]octane derivatives as M4 agonists

2-azaspiro[3.4]octane derivatives as M4 agonists

2-azaspiro[3.4]octane derivatives as M4 agonists

Patents Applicationslast 30 patents

SUBSTITUTED TETRAHYDROPYRROLO-PYRIDINONE COMPOUNDS AND THEIR USE IN...

"Cyclopenta[c]pyrrol Negative Allosteric Modulators of NR2B"

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS